Follow
Larissa Pontes
Larissa Pontes
Verified email at alu.ufc.br
Title
Cited by
Cited by
Year
Boosting half-life and effector functions of therapeutic antibodies by Fc-engineering: An interaction-function review
MHG Fonseca, GP Furtado, MRL Bezerra, LQ Pontes, CFC Fernandes
International journal of biological macromolecules 119, 306-311, 2018
282018
Epigenetic reprogramming in cancer: From diagnosis to treatment
PMS Costa, SLA Sales, DP Pinheiro, LQ Pontes, SSA Maranhão, ...
Frontiers in cell and developmental biology 11, 1116805, 2023
262023
Progress on phage display technology: tailoring antibodies for cancer immunotherapy
RKA França, IC Studart, MRL Bezerra, LQ Pontes, AMA Barbosa, ...
Viruses 15 (9), 1903, 2023
142023
Ethnopharmacological and Genetic Study on the Treatment of Mental Disorders: a Systematic Review
CKT Lima, LQ Pontes, LG Pinho, MRL Bezerra, W da Silva Barroso, ...
International Archives of Medicine 8, 2015
22015
Ultrastructural aspects of cranial and peripheric nerves of cronically diabetic and malnourished rats: a short biochemical panorama
A de Oliveira Saraiva, LQ Pontes, LG Pinho, MRL Bezerra, HA Braga, ...
International Archives of Medicine 8, 2015
12015
Kinetics characterization of a low immunogenic recombinant l-asparaginase from Phaseolus vulgaris with cytotoxic activity against leukemia cells
JG da Silva Gomes, LC Brandão, DP Pinheiro, LQ Pontes, RF Carneiro, ...
International Journal of Biological Macromolecules 275, 133731, 2024
2024
Physical Activity at Different Life Stages and Its Consequence on the Initial Immunization and Inflammatory Response Against COVID-19
PAQ Rossi, R Gomes, TC do Nascimento Salazar, EML Barros, ...
Journal of Physical Activity and Health 1 (aop), 1-9, 2024
2024
Reconversion of rituximab’s scFv into FvFc: a suitable format to understand CDR mutations of monoclonal antibodies
MR Bezerra, PEG Saraiva Filho, LQ Pontes, DP Pinheiro, RPS Araújo, ...
Instituto de Tecnologia em Imunobiológicos, 2024
2024
Proposição de fragmentos de anticorpo de domínio variável (scFv) anti-CD20 para o desenvolvimento de bispecíficos t-cell engager (BiTE)
LQ Pontes
2023
CAR-T Cells and Other Related Technologies
MRL Bezerra, LQ Pontes, IC Studart, B de Sousa Lima, GP Furtado
The Golden Guide to Oncologic Pharmacy, 281-314, 2022
2022
Selection of human antibody fragments by phage display: development of new anti-CD19 molecules for CAR-T cell therapies
MRL Bezerra, LQ Pontes, AQ Maranhão, GP Furtado
Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2021
2021
Construção, por desenho racional, e caracterização de variantes de afinidade da região variável do anticorpo monoclonal Rituximabe
LQ Pontes
2019
Construction, by rational design, and initial characterization of affinity mutants of Rituximab fragment antibody
LQ Pontes, MRL Bezerra, MHG Fonseca, MR Lourenzoni, GP Furtado
Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2019
2019
Construction of a scFv library using directed evolution for rituximab-based therapies: using phage display towards antibody affinity maturation
MRL Bezerra, AQ Maranhao, IC Studart, LQ Pontes, MHG Fonseca, ...
Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–14